| Optical Expressions Berlin, Llc | |
|
14 N Main St Ste 4002, Barre, VT 05641-4505 | |
| (802) 223-2090 | |
| (802) 223-5336 |
| Full Name | Optical Expressions Berlin, Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 14 N Main St Ste 4002, Barre, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740442417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | L0023504 (Vermont) | Primary |
| Provider Name | Mark A Leipert |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134234438 PECOS PAC ID: 1850468372 Enrollment ID: I20081203000280 |
News Archive
New data presented today at the Society for Cardiovascular Angiography and Interventions Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting.
Popular Mechanics has recognized three NSF-funded projects with innovation Breakthrough Awards: an artificial retina returning sight to those who have lost it; a system that uses "controlled rocking" and energy-dissipating fuses to help buildings withstand earthquakes; and an inexpensive medical microscope built for cell-phones that allows doctors in rural villages to identify malaria-infected blood cells.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. and a leading Contract Research Organization with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer technology.
CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.
Results from a two-year retrospective cohort study presented at the 63rd Annual Meeting of the American Academy of Neurology, Hawaii, U.S., showed that patients were significantly more likely to develop cardiovascular conditions, including hypertension, cardiac dysrhythmias and chronic ischemic heart diseases after an initial diagnosis of RLS, as compared to controls without RLS.
› Verified 1 days ago
| Provider Name | Garuna Hartnett |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346497062 PECOS PAC ID: 2860551405 Enrollment ID: I20120810000213 |
News Archive
New data presented today at the Society for Cardiovascular Angiography and Interventions Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting.
Popular Mechanics has recognized three NSF-funded projects with innovation Breakthrough Awards: an artificial retina returning sight to those who have lost it; a system that uses "controlled rocking" and energy-dissipating fuses to help buildings withstand earthquakes; and an inexpensive medical microscope built for cell-phones that allows doctors in rural villages to identify malaria-infected blood cells.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. and a leading Contract Research Organization with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer technology.
CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.
Results from a two-year retrospective cohort study presented at the 63rd Annual Meeting of the American Academy of Neurology, Hawaii, U.S., showed that patients were significantly more likely to develop cardiovascular conditions, including hypertension, cardiac dysrhythmias and chronic ischemic heart diseases after an initial diagnosis of RLS, as compared to controls without RLS.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Optical Expressions Berlin, Llc 14 N Main St Ste 4002, Barre, VT 05641-4505 Ph: (802) 223-2090 | Optical Expressions Berlin, Llc 14 N Main St Ste 4002, Barre, VT 05641-4505 Ph: (802) 223-2090 |
News Archive
New data presented today at the Society for Cardiovascular Angiography and Interventions Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting.
Popular Mechanics has recognized three NSF-funded projects with innovation Breakthrough Awards: an artificial retina returning sight to those who have lost it; a system that uses "controlled rocking" and energy-dissipating fuses to help buildings withstand earthquakes; and an inexpensive medical microscope built for cell-phones that allows doctors in rural villages to identify malaria-infected blood cells.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. and a leading Contract Research Organization with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer technology.
CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.
Results from a two-year retrospective cohort study presented at the 63rd Annual Meeting of the American Academy of Neurology, Hawaii, U.S., showed that patients were significantly more likely to develop cardiovascular conditions, including hypertension, cardiac dysrhythmias and chronic ischemic heart diseases after an initial diagnosis of RLS, as compared to controls without RLS.
› Verified 1 days ago
David Glen Ripley, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16 East St, Barre, VT 05641 Phone: 802-476-2020 Fax: 802-476-4818 | |
Dr. James M. Foley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 341 North Main Street, Barre, VT 05641 Phone: 802-476-7932 Fax: 802-479-5523 |